Vicapsys Life Sciences, Inc. (VICP) — Operating Cash Flow
| Fiscal Year | Operating Cash Flow | Change YoY |
|---|---|---|
| 2023 | -$417.5K | -75.3% |
| 2022 | -$238.2K | +46.3% |
| 2021 | -$444.0K | -68.9% |
| 2020 | -$262.9K | +72.9% |
| 2019 | -$970.3K | — |
| Fiscal Year | Operating Cash Flow | Change YoY |
|---|---|---|
| 2023 | -$417.5K | -75.3% |
| 2022 | -$238.2K | +46.3% |
| 2021 | -$444.0K | -68.9% |
| 2020 | -$262.9K | +72.9% |
| 2019 | -$970.3K | — |